Medical Director, Principal Investigator
With nearly two decades of clinical research experience, Dr. Jambrecina has strong research expertise in vaccines across a wide range of therapeutic areas, including Ebola and MERS-CoV. He also has demonstrated success in conducting clinical research serving as both the Director of the Clinical Unit and Deputy Head Investigator at Clinical Trial Center North GmBH in Hamburg, Germany before joining Velocity in 2023.
